▶ 調査レポート

全身麻酔薬の世界市場レポート2020

• 英文タイトル:Global General Anesthesia Drugs Sales Market Report 2020

Global General Anesthesia Drugs Sales Market Report 2020「全身麻酔薬の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-07109
• 出版社/出版日:QYResearch / 2020年6月2日
• レポート形態:英文、PDF、142ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥552,000 (USD4,000)▷ お問い合わせ
  Multi User¥828,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,104,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、全身麻酔薬のグローバル市場について種類別(プロポフォール、エトミダート、ミダゾラム、セボフルラン、イソフルラン、その他)、用途別(静脈麻酔薬、吸入麻酔薬)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・全身麻酔薬市場の概要
・世界の主要地域別全身麻酔薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の全身麻酔薬市場規模2015-2026:種類別(プロポフォール、エトミダート、ミダゾラム、セボフルラン、イソフルラン、その他)
・世界の全身麻酔薬市場規模2015-2026:用途別(静脈麻酔薬、吸入麻酔薬)
・全身麻酔薬の北米市場規模2015-2020
・全身麻酔薬のヨーロッパ市場規模2015-2020
・全身麻酔薬の中国市場規模2015-2020
・全身麻酔薬の日本市場規模2015-2020
・全身麻酔薬の東南アジア市場規模2015-2020
・全身麻酔薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan)
・全身麻酔薬の製造コスト分析
・販売チャネル、流通業者、顧客
・全身麻酔薬の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global General Anesthesia Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global General Anesthesia Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the General Anesthesia Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the General Anesthesia Drugs industry.
Based on our recent survey, we have several different scenarios about the General Anesthesia Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 6877.8 million in 2019. The market size of General Anesthesia Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global General Anesthesia Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global General Anesthesia Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global General Anesthesia Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global General Anesthesia Drugs market. The report also includes nautical information, where it shows General Anesthesia Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global General Anesthesia Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global General Anesthesia Drugs market.
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
Geographical Analysis:
Based on region, the global General Anesthesia Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global General Anesthesia Drugs market are
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Segment by Type
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global General Anesthesia Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global General Anesthesia Drugs market.
• The market share of the global General Anesthesia Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global General Anesthesia Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global General Anesthesia Drugs market.

レポート目次

1 General Anesthesia Drugs Market Overview
1.1 General Anesthesia Drugs Product Scope
1.2 General Anesthesia Drugs Segment by Type
1.2.1 Global General Anesthesia Drugs Sales by Type (2020-2026)
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 General Anesthesia Drugs Segment by Application
1.3.1 Global General Anesthesia Drugs Sales Comparison by Application (2020-2026)
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 General Anesthesia Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global General Anesthesia Drugs Sales Growth Rate (2015-2026)
1.4.2 Global General Anesthesia Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global General Anesthesia Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): General Anesthesia Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the General Anesthesia Drugs Industry
1.5.1.1 General Anesthesia Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and General Anesthesia Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for General Anesthesia Drugs Players to Combat Covid-19 Impact

2 General Anesthesia Drugs Estimate and Forecast by Region
2.1 Global General Anesthesia Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global General Anesthesia Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global General Anesthesia Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global General Anesthesia Drugs Revenue Market Share by Region (2015-2020)
2.3 Global General Anesthesia Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global General Anesthesia Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global General Anesthesia Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States General Anesthesia Drugs Estimates and Projections (2015-2026)
2.4.2 Europe General Anesthesia Drugs Estimates and Projections (2015-2026)
2.4.3 China General Anesthesia Drugs Estimates and Projections (2015-2026)
2.4.4 Japan General Anesthesia Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia General Anesthesia Drugs Estimates and Projections (2015-2026)
2.4.6 India General Anesthesia Drugs Estimates and Projections (2015-2026)
3 Global General Anesthesia Drugs Competition Landscape by Players
3.1 Global Top General Anesthesia Drugs Players by Sales (2015-2020)
3.2 Global Top General Anesthesia Drugs Players by Revenue (2015-2020)
3.3 Global General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anesthesia Drugs as of 2019)
3.4 Global General Anesthesia Drugs Average Price by Company (2015-2020)
3.5 Manufacturers General Anesthesia Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key General Anesthesia Drugs Players (Opinion Leaders)
4 Global General Anesthesia Drugs Market Size by Type
4.1 Global General Anesthesia Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global General Anesthesia Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global General Anesthesia Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global General Anesthesia Drugs Price by Type (2014-2020)
4.2 Global General Anesthesia Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global General Anesthesia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global General Anesthesia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global General Anesthesia Drugs Price Forecast by Type (2021-2026)
5 Global General Anesthesia Drugs Market Size by Application
5.1 Global General Anesthesia Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global General Anesthesia Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global General Anesthesia Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global General Anesthesia Drugs Price by Application (2015-2020)
5.2 Global General Anesthesia Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global General Anesthesia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global General Anesthesia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global General Anesthesia Drugs Price Forecast by Application (2021-2026)

3 North America General Anesthesia Drugs Market Facts & Figures
3.2 North America General Anesthesia Drugs Sales Market Share by Company (2015-2020)
3.3 North America General Anesthesia Drugs Sales Market Share by Type (2015-2020)
3.4 North America General Anesthesia Drugs Sales Market Share by Application (2015-2020)

4 Europe General Anesthesia Drugs Market Facts & Figures
4.2 Europe General Anesthesia Drugs Sales Market Share by Company (2015-2020)
4.3 Europe General Anesthesia Drugs Sales Market Share by Type (2015-2020)
4.4 Europe General Anesthesia Drugs Sales Market Share by Application (2015-2020)

5 China General Anesthesia Drugs Market Facts & Figures
5.2 China General Anesthesia Drugs Sales Market Share by Company (2015-2020)
5.3 China General Anesthesia Drugs Sales Market Share by Type (2015-2020)
5.4 China General Anesthesia Drugs Sales Market Share by Application (2015-2020)

6 Japan General Anesthesia Drugs Market Facts & Figures
6.2 Japan General Anesthesia Drugs Sales Market Share by Company (2015-2020)
6.3 Japan General Anesthesia Drugs Sales Market Share by Type (2015-2020)
6.4 Japan General Anesthesia Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia General Anesthesia Drugs Market Facts & Figures
7.2 Southeast Asia General Anesthesia Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia General Anesthesia Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia General Anesthesia Drugs Sales Market Share by Application (2015-2020)

8 India General Anesthesia Drugs Market Facts & Figures
8.2 India General Anesthesia Drugs Sales Market Share by Company (2015-2020)
8.3 India General Anesthesia Drugs Sales Market Share by Type (2015-2020)
8.4 India General Anesthesia Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in General Anesthesia Drugs Business
12.1 Astrazeneca
12.1.1 Astrazeneca General Anesthesia Drugs Corporation Information
12.1.2 Astrazeneca General Anesthesia Drugs Business Overview and Total Revenue
12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astrazeneca General Anesthesia Drugs Products Offered
12.1.5 Astrazeneca Recent Development
12.2 Fresenius-Kabi
12.2.1 Fresenius-Kabi General Anesthesia Drugs Corporation Information
12.2.2 Fresenius-Kabi General Anesthesia Drugs Business Overview and Total Revenue
12.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Fresenius-Kabi General Anesthesia Drugs Products Offered
12.2.5 Fresenius-Kabi Recent Development
12.3 AbbVie
12.3.1 AbbVie General Anesthesia Drugs Corporation Information
12.3.2 AbbVie General Anesthesia Drugs Business Overview and Total Revenue
12.3.3 AbbVie General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie General Anesthesia Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 Baxter Healthcare
12.4.1 Baxter Healthcare General Anesthesia Drugs Corporation Information
12.4.2 Baxter Healthcare General Anesthesia Drugs Business Overview and Total Revenue
12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Baxter Healthcare General Anesthesia Drugs Products Offered
12.4.5 Baxter Healthcare Recent Development
12.5 B.Braun
12.5.1 B.Braun General Anesthesia Drugs Corporation Information
12.5.2 B.Braun General Anesthesia Drugs Business Overview and Total Revenue
12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 B.Braun General Anesthesia Drugs Products Offered
12.5.5 B.Braun Recent Development
12.6 Maruishi
12.6.1 Maruishi General Anesthesia Drugs Corporation Information
12.6.2 Maruishi General Anesthesia Drugs Business Overview and Total Revenue
12.6.3 Maruishi General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Maruishi General Anesthesia Drugs Products Offered
12.6.5 Maruishi Recent Development
12.7 Piramal
12.7.1 Piramal General Anesthesia Drugs Corporation Information
12.7.2 Piramal General Anesthesia Drugs Business Overview and Total Revenue
12.7.3 Piramal General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Piramal General Anesthesia Drugs Products Offered
12.7.5 Piramal Recent Development
12.8 Hikma Pharmaceuticals
12.8.1 Hikma Pharmaceuticals General Anesthesia Drugs Corporation Information
12.8.2 Hikma Pharmaceuticals General Anesthesia Drugs Business Overview and Total Revenue
12.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Products Offered
12.8.5 Hikma Pharmaceuticals Recent Development
12.9 Mylan
12.9.1 Mylan General Anesthesia Drugs Corporation Information
12.9.2 Mylan General Anesthesia Drugs Business Overview and Total Revenue
12.9.3 Mylan General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mylan General Anesthesia Drugs Products Offered
12.9.5 Mylan Recent Development
12.10 Nhwa
12.10.1 Nhwa General Anesthesia Drugs Corporation Information
12.10.2 Nhwa General Anesthesia Drugs Business Overview and Total Revenue
12.10.3 Nhwa General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nhwa General Anesthesia Drugs Products Offered
12.10.5 Nhwa Recent Development
12.11 Hengrui
12.11.1 Hengrui General Anesthesia Drugs Corporation Information
12.11.2 Hengrui General Anesthesia Drugs Business Overview and Total Revenue
12.11.3 Hengrui General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hengrui General Anesthesia Drugs Products Offered
12.11.5 Hengrui Recent Development
12.12 Lunan
12.12.1 Lunan General Anesthesia Drugs Corporation Information
12.12.2 Lunan General Anesthesia Drugs Business Overview and Total Revenue
12.12.3 Lunan General Anesthesia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Lunan General Anesthesia Drugs Products Offered
12.12.5 Lunan Recent Development

13 General Anesthesia Drugs Manufacturing Cost Analysis
13.1 General Anesthesia Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of General Anesthesia Drugs
13.4 General Anesthesia Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 General Anesthesia Drugs Distributors List
14.3 General Anesthesia Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global General Anesthesia Drugs Sales (K L) Growth Rate by Type (2020-2026)
Table 2. Global General Anesthesia Drugs Sales (K L) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four General Anesthesia Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for General Anesthesia Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for General Anesthesia Drugs Players to Combat Covid-19 Impact
Table 8. Global Market General Anesthesia Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global General Anesthesia Drugs Sales (K L) by Region (2015-2020)
Table 10. Global General Anesthesia Drugs Sales Market Share by Region (2015-2020)
Table 11. Global General Anesthesia Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global General Anesthesia Drugs Revenue Share by Region (2015-2020)
Table 13. Global General Anesthesia Drugs Sales (K L) Forecast by Region (2021-2026)
Table 14. Global General Anesthesia Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global General Anesthesia Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global General Anesthesia Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global General Anesthesia Drugs (K L) of Key Companies (2015-2020)
Table 18. Global General Anesthesia Drugs Sales Share by Company (2015-2020)
Table 19. Global General Anesthesia Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global General Anesthesia Drugs Revenue Share by Company (2015-2020)
Table 21. Global General Anesthesia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anesthesia Drugs as of 2019)
Table 22. Global General Anesthesia Drugs Average Price (USD/L) of Key Company (2015-2020)
Table 23. Manufacturers General Anesthesia Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers General Anesthesia Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key General Anesthesia Drugs Players
Table 27. Global General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 28. Global General Anesthesia Drugs Sales Share by Type (2015-2020)
Table 29. Global General Anesthesia Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global General Anesthesia Drugs Price (K L) by Type (2015-2020)
Table 31. Global General Anesthesia Drugs Sales Share by Type (2021-2026)
Table 32. Global General Anesthesia Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global General Anesthesia Drugs Revenue Share by Type (2021-2026)
Table 34. Global General Anesthesia Drugs Price (K L) by Type (2021-2026)
Table 35. Global General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 36. Global General Anesthesia Drugs Sales Share by Application (2015-2020)
Table 37. Global General Anesthesia Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global General Anesthesia Drugs Price (K L) by Application (2015-2020)
Table 39. Global General Anesthesia Drugs Sales (K L) by Application (2021-2026)
Table 40. Global General Anesthesia Drugs Sales Share by Application (2021-2026)
Table 41. Global General Anesthesia Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global General Anesthesia Drugs Revenue Share by Application (2021-2026)
Table 43. Global General Anesthesia Drugs Price (K L) by Application (2021-2026)
Table 44. United States General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 45. United States General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 46. United States General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 47. United States General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 48. United States General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 49. United States General Anesthesia Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 51. Europe General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 53. Europe General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 55. Europe General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 56. China General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 57. China General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 58. China General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 59. China General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 60. China General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 61. China General Anesthesia Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 63. Japan General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 65. Japan General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 67. Japan General Anesthesia Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 69. Southeast Asia General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 71. Southeast Asia General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 73. Southeast Asia General Anesthesia Drugs Sales Market Share by Application (2015-2020)
Table 74. India General Anesthesia Drugs Sales (K L) by Company (2015-2020)
Table 75. India General Anesthesia Drugs Sales Market Share by Company (2015-2020)
Table 76. India General Anesthesia Drugs Sales (K L) by Type (2015-2020)
Table 77. India General Anesthesia Drugs Sales Market Share by Type (2015-2020)
Table 78. India General Anesthesia Drugs Sales (K L) by Application (2015-2020)
Table 79. India General Anesthesia Drugs Sales Market Share by Application (2015-2020)
Table 80. Astrazeneca Corporation Information
Table 81. Astrazeneca Description and Business Overview
Table 82. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 83. Astrazeneca General Anesthesia Drugs Product
Table 84. Astrazeneca Recent Development
Table 85. Fresenius-Kabi Corporation Information
Table 86. Fresenius-Kabi Description and Business Overview
Table 87. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 88. Fresenius-Kabi General Anesthesia Drugs Product
Table 89. Fresenius-Kabi Recent Development
Table 90. AbbVie Corporation Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 93. AbbVie General Anesthesia Drugs Product
Table 94. AbbVie Recent Development
Table 95. Baxter Healthcare Corporation Information
Table 96. Baxter Healthcare Description and Business Overview
Table 97. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 98. Baxter Healthcare General Anesthesia Drugs Product
Table 99. Baxter Healthcare Recent Development
Table 100. B.Braun Corporation Information
Table 101. B.Braun Description and Business Overview
Table 102. B.Braun General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 103. B.Braun General Anesthesia Drugs Product
Table 104. B.Braun Recent Development
Table 105. Maruishi Corporation Information
Table 106. Maruishi Description and Business Overview
Table 107. Maruishi General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 108. Maruishi General Anesthesia Drugs Product
Table 109. Maruishi Recent Development
Table 110. Piramal Corporation Information
Table 111. Piramal Description and Business Overview
Table 112. Piramal General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 113. Piramal General Anesthesia Drugs Product
Table 114. Piramal Recent Development
Table 115. Hikma Pharmaceuticals Corporation Information
Table 116. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Hikma Pharmaceuticals Description and Business Overview
Table 118. Hikma Pharmaceuticals General Anesthesia Drugs Product
Table 119. Hikma Pharmaceuticals Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 122. Mylan Description and Business Overview
Table 123. Mylan General Anesthesia Drugs Product
Table 124. Mylan Recent Development
Table 125. Nhwa Corporation Information
Table 126. Nhwa Description and Business Overview
Table 127. Nhwa General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 128. Nhwa General Anesthesia Drugs Product
Table 129. Nhwa Recent Development
Table 130. Hengrui Corporation Information
Table 131. Hengrui Description and Business Overview
Table 132. Hengrui General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table 133. Hengrui General Anesthesia Drugs Product
Table 134. Hengrui Recent Development
Table . Lunan Corporation Information
Table . Lunan Description and Business Overview
Table . Lunan General Anesthesia Drugs Sales (K L), Revenue (Million USD), Price (USD/L) and Gross Margin (2015-2020)
Table . Lunan General Anesthesia Drugs Product
Table . Lunan Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. General Anesthesia Drugs Distributors List
Table 143. General Anesthesia Drugs Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. General Anesthesia Drugs Product Picture
Figure 2. Global General Anesthesia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global General Anesthesia Drugs Market Share by Application in 2020 & 2026
Figure 6. Intravenous Anesthetics Examples
Figure 7. Inhalational Anesthetics Examples
Figure 8. Global General Anesthesia Drugs Sales (K L) Growth Rate (2015-2026)
Figure 9. Global General Anesthesia Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global General Anesthesia Drugs Price Trends Growth Rate (2015-2026) (USD/L)
Figure 11. Global General Anesthesia Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global General Anesthesia Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States General Anesthesia Drugs Sales (K L) Growth Rate (2015-2026)
Figure 15. Europe General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe General Anesthesia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China General Anesthesia Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan General Anesthesia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia General Anesthesia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India General Anesthesia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India General Anesthesia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest General Anesthesia Drugs Players Market Share by Revenue in General Anesthesia Drugs 2015 & 2019
Figure 26. General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global General Anesthesia Drugs Revenue Share by Type (2015-2020)
Figure 28. Global General Anesthesia Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global General Anesthesia Drugs Revenue Share by Application (2015-2020)
Figure 30. Global General Anesthesia Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 32. United States General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 33. Europe General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 34. Europe General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 35. Europe General Anesthesia Drugs Sales Market Share by Application in 2019
Figure 36. China General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 37. China General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 38. China General Anesthesia Drugs Sales Market Share by Application in 2019
Figure 39. Japan General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 40. Japan General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 41. Japan General Anesthesia Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia General Anesthesia Drugs Sales Market Share by Application in 2019
Figure 45. India General Anesthesia Drugs Sales Market Share by Company in 2019
Figure 46. India General Anesthesia Drugs Sales Market Share by Type in 2019
Figure 47. India General Anesthesia Drugs Sales Market Share by Application in 2019
Figure 48. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Fresenius-Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Baxter Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. B.Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Maruishi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Piramal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Nhwa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hengrui Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Lunan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of General Anesthesia Drugs
Figure 62. Manufacturing Process Analysis of General Anesthesia Drugs
Figure 63. General Anesthesia Drugs Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed